Insiders · Profile

CAPELLO JEFFREY D

Director at NEOGEN · EVP & Chief Financial Officer at Boston Scientific · Director at Tempest Therapeutics · and 1 more. Filing since 31 May 2007. CIK 0001224108

Company
Date
Role
Action
Shares
Amount
Of holding
22 Apr 2025
Director
Bought
20,712
$100.22K
350%
27 Nov 2013
EVP & Chief Financial Officer
Sold, plan not stated
108,595
$1.27M
99.6%
26 Nov 2013
EVP & Chief Financial Officer
Sold, plan not stated
85,106
$1.01M
43.8%
25 Nov 2013
EVP & Chief Financial Officer
Sold, plan not stated
242,504
$2.92M
62.2%
22 Nov 2013
EVP & Chief Financial Officer
Sold, plan not stated
150,000
$1.80M
50.4%
29 Aug 2013
EVP & Chief Financial Officer
Sold, plan not stated
525,000
$5.61M
78.1%
18 Mar 2013
Director
Bought
11,111
$100.00K
opened
31 May 2007
SVP & CFO
Sold, plan not stated
37,500
$989.90K
33.9%
8 decisions on file.